1Giamarellou Bourboulis EJ,Sambatakou H, Grecka P, et al. Sitaflo xacin and trovafloxacin:postantibiotic effect andin vitro interactions with rif ampin on methicillin-resistant staphylococus aureus. DiagnMicribiol Infect Dis, 1999,34(4):301
2Rodriguez Cruz MS, Gonzalez Alonso I, Sanchez Navarro A, et al. I nvitro study ofthe interaction between quinolones and polyvalent cations. Pharm Acta Helv, 1999,73(5):237
3Fernandes PB. Mode of Action, and in vitro and in vivo activities of thefluoroquinolones. J Clin Pharmacol,1988,28:156
4Kinzig Schippers M, Fuhr U, Cesana M, et al. Absence of effect of rufloxacin ontheophylline pharmacokinetics in steady state. Antimicrob Agents Chemother,1998,42(9):2359
5Niki Y, Itokawa K, Okazaki O. Effects of DU-6859a, a new quinolon e antimicrobial,on theophylline metabolism in vitro and in vivo studies. Antimi crob Agents Chemother,1998,42(7):1751
6尤华.诺氟沙星致支气管哮喘发作1例[J].药物流行病杂志,1994,3(1):36-36.
7Schentag JJ,Goss TF. Quinolone pharmacokinetics in the elderly. A m JMed,1992,92:33s
8Wolfson JS. Quinolone antimicrobial agents:adverse effects and ba cterialresistance. Eur J Clin Microbiol Infect Dis. 1989,8(12):1080
9Ball P, Tillotson G. Tolerability of fluoroquinolone antibiotics . Past, presentand future. Drug Saf,1995,13:343
10Brouwers JR. Drug interactions with quinolone antibacterials. Dr ug Saf,1992,7:268
